Junson Capital
13
36M
12
1.18
0.08
- Areas of investment
Summary
The fund was located in Asia if to be more exact in Hong Kong. The main office of represented VC is situated in the Hong Kong.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Junson Capital, startups are often financed by YuanMing Capital, Viventures, Sinopharm Capital. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, StartX (Stanford-StartX Fund), South China Venture Capital.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
The overall number of key employees were 3.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ansun BioPharma, Apollomics, MultiVu Technologies. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Security, Medical. The fund has no exact preference in a number of founders of portfolio startups.
Investments analytics
Analytics
- Total investments
- 13
- Lead investments
- 0
- Rounds per year
- 1.18
- Follow on index
- 0.08
- Investments by industry
- Biotechnology (6)
- Health Care (6)
- Security (2)
- Pharmaceutical (2)
- Manufacturing (2) Show 13 more
- Investments by region
-
- United States (8)
- China (3)
- United Kingdom (1)
- Israel (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Full-Life Technologies | 03 Jan 2024 | Health Care, Manufacturing, Pharmaceutical | Early Stage Venture | 47M | Shanghai, Shanghai, China |
| MabPlex International | 17 Jan 2019 | Non Profit, Association | Early Stage Venture | 61M | United States, California, Fremont |
| Worg Pharmaceuticals | 18 Jan 2021 | Biotechnology | Early Stage Venture | 30M | Zhejiang, Shangcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.